Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer J. 2012 Jan-Feb;18(1):26-31. doi: 10.1097/PPO.0b013e318244d7c8.

Neuroimaging: diagnosis and response assessment in glioblastoma.

Author information

  • 1Department of Neurological Surgery, Division of Neuro-Oncology, University of California-San Francisco, San Francisco, CA 94143-0372, USA. clarkej@neurosurg.ucsf.edu

Abstract

Glioblastoma is the most common primary malignant brain tumor; standard initial treatment includes a combination of radiation and temozolomide, and treatment at recurrence often includes the use of antiangiogenic agents. Characterization of tumor at initial diagnosis, assessment of response, and ability to distinguish viable tumor from treatment effects are ongoing challenges in neuroimaging. Progress has been made with the new Response Assessment in Neuro-Oncology criteria, and new imaging modalities and combinations continue to be evaluated to further improve our ability to characterize glioblastomas at all points during their disease course.

PMID:
22290254
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk